- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Zolgensma and Spinraza the Same Thing?
Spinraza is also used to treat spinal muscular atrophy (SMA) in adult patients.
Zolgensma and Spinraza belong to different drug classes. Zolgensma is an adeno-associated virus vector-based gene therapy and Spinraza is a survival motor neuron-2 (SMN2)- directed antisense oligonucleotide.
Side effects of Zolgensma that are different from Spinraza include elevated aminotransferases and vomiting.
Spinraza may interact with other drugs.
What Are Possible Side Effects of Zolgensma?
Side effects of Zolgensma include:
- elevated aminotransferases and
What Are Possible Side Effects of Spinraza?
Common side effects of Spinraza include:
What Is Zolgensma?
Zolgensma (onasemnogene abeparvovec-xioi) is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.
What Drugs Interact With Zolgensma?
Zolgensma may interact with corticosteroids and certain vaccines, such as MMR and varicella.
What Drugs Interact With Spinraza?
Spinraza may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Spinraza; it is unknown if it will affect a fetus. It is unknown if Spinraza passes into breast milk. Consult your doctor before breastfeeding.
How Should Zolgensma be Taken?
The recommended dosage of Zolgensma is 1.1×1014 vector genomes (vg) per kg of body weight.
How Should Spinraza be Taken?
The recommended dosage of Spinraza is 12 mg (5 mL) per administration. Initiate Spinraza treatment with 4 loading doses. The first three loading doses should be administered at 14-day intervals. The 4th loading dose should be administered 30 days after the 3rd dose. A maintenance dose should be administered once every 4 months thereafter.
Brain and Nervous System Resources
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Biogennraza Product Information.